急性卒中串联病变取栓术后延迟性支架血栓形成的预测因素与临床影响
单中心回顾性研究纳入2009年1月至2018年4月因前循环串联病变行取栓术的81例患者,回顾性分析延迟性支架血栓形成的预测因素及出院临床结局。结果显示延迟性支架血栓形成率为19.1%,与入院NIHSS评分高、糖尿病及最终造影见支架内血栓独立相关,且为出院不良结局的独立预测因素。
要点
- 串联病变取栓术后延迟性支架血栓形成率为19.1%,与入院NIHSS评分高、糖尿病及最终造影见支架内血栓独立相关。
- 围术期单用阿司匹林者支架闭塞率28.2%,高于阿司匹林联合氯吡格雷者的8.8%(P = .04)。
- 延迟性支架血栓形成是出院不良结局的独立预测因素(OR 19.78)。
核心结论
- 延迟性支架血栓形成发生率不容忽视,且对临床结局有显著负面影响;未来研究应系统测量并报告支架通畅率。
研究设计与样本
- 单中心回顾性研究,纳入2009年1月至2018年4月因前循环串联病变行取栓术的患者81例。
- 患者病变类型:动脉粥样硬化63例(77.7%)、夹层17例(20.9%)、颈动脉蹼1例(1.2%)。
- 回顾患者病历提取患者特征、手术细节、影像学检查及临床信息,采用单因素和多因素分析延迟性支架血栓形成的预测因素及出院临床结局。
关键影像表现/征象
- TICI 2b-3再通70例(86.4%)。
- 出院时35例(43.2%)功能独立(mRS评分≤2)。
- 在73例颅内再通且术毕支架通畅的患者中,14例(19.1%)观察到延迟性支架血栓形成。
- 在59例支架通畅的患者中,44例有进一步影像学随访(中位105天,范围2-2407天),其中1例(1.6%)出现50%支架内狭窄且未再治疗。
诊断标准与关键数值
- 延迟性支架血栓形成的独立相关因素:入院NIHSS评分较高(OR 1.1,95% CI 1.01-1.28)、糖尿病(OR 6.07,95% CI 1.2-30.6)、最终造影见支架内血栓(OR 6.2,95% CI 1.4-27.97)。
- 出院不良临床结局的独立预测因素:延迟性支架血栓形成(OR 19.78,95% CI 2.78-296.83)、入院NIHSS评分较高(OR 1.27,95% CI 1.12-1.51)、症状性出血转化(OR 23.65,95% CI 1.85-3478.94)。
- 支架闭塞率:围术期阿司匹林治疗组11/39(28.2%),阿司匹林联合氯吡格雷组3/34(8.8%),P = .04。
临床应用与阅片要点
- 原文未据此给出推荐。
- 作者指出未来研究应系统测量并报告支架通畅率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: There are very few published data on the patency of carotid stents implanted during thrombectomies for tandem lesions in the anterior circulation. We aimed to communicate our experience of stenting in the acute setting with systematic follow-up of stent patency and discuss predictors and clinical repercussions of delayed stent thrombosis.
MATERIALS AND METHODS: We performed a retrospective study of stroke thrombectomies in a single center between January 2009 and April 2018. Patient files were reviewed to extract patient characteristics, procedural details, imaging studies, and clinical information. Predictors of delayed stent thrombosis and clinical outcome at discharge were analyzed using univariate and multivariate analyses.
RESULTS: We identified 81 patients treated for tandem lesions: 63 (77.7%) atheromas, 17 (20.9%) dissections, and 1 (1.2%) carotid web. TICI 2b-3 recanalization was achieved in 70 (86.4%) cases. Thirty-five patients (43.2%) were independent (mRS score ≤ 2) at discharge. Among 73 patients with intracranial recanalization and patent stents at the end of the procedure, delayed stent thrombosis was observed in 14 (19.1%). Among 59 patients with patent stents, 44 had further imaging controls (median, 105 days; range, 2-2407 days) and 1 (1.6%) had 50% in-stent stenosis with no retreatment. Stent occlusion rates were 11/39 (28.2%) for periprocedural aspirin treatment versus 3/34 (8.8%) for aspirin and clopidogrel (P = .04). Delayed stent thrombosis was independently associated with higher admission NIHSS scores (OR, 1.1; 95% CI, 1.01-1.28), diabetes (OR, 6.07; 95% CI, 1.2-30.6), and the presence of in-stent thrombus on the final angiographic run (OR, 6.2; 95% CI, 1.4-27.97). Delayed stent thrombosis (OR, 19.78; 95% CI, 2.78-296.83), higher admission NIHSS scores (OR, 1.27, 95% CI, 1.12-1.51), and symptomatic hemorrhagic transformation (OR, 23.65; 95% CI, 1.85-3478.94) were independent predictors of unfavorable clinical outcome at discharge.
CONCLUSIONS: We observed a non-negligible rate of delayed stent thrombosis with significant negative impact on clinical outcome. Future studies should systematically measure and report stent patency rates.
引用
- Pop R, Zinchenko I, Quenardelle V, et al. Predictors and Clinical Impact of Delayed Stent Thrombosis after Thrombectomy for Acute Stroke with Tandem Lesions. AJNR Am J Neuroradiol. 2019. PMID: 30765378. doi:10.3174/ajnr.A5976
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。